Should Hysingla (hydrocodone bitartrate) be taken with food?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hysingla Administration with Food

Hysingla (hydrocodone bitartrate extended-release) can be taken with or without food, as food does not significantly affect its absorption or clinical efficacy. However, taking it with food may help reduce gastrointestinal side effects if they occur.

Administration Guidelines

Standard Dosing Approach

  • Hysingla ER is formulated for once-daily oral administration and provides consistent plasma hydrocodone concentrations over the 24-hour dosing interval regardless of food intake 1.
  • The medication can be taken at any time of day, with or without meals, based on patient preference and tolerability 2.

Managing Gastrointestinal Side Effects

  • If nausea, vomiting, or other GI distress occurs, taking Hysingla with food is a reasonable strategy to improve tolerability without compromising analgesic efficacy 3, 4.
  • This approach mirrors recommendations for other medications that can cause gastric upset, where food administration helps reduce side effects while maintaining therapeutic benefit 3.

Important Safety Considerations

Common Opioid Side Effects

  • Like all opioid analgesics, Hysingla commonly causes constipation (which does not improve over time), nausea, vomiting, and sedation 5.
  • Prophylactic bowel regimen with stool softeners and stimulant laxatives should be initiated when starting Hysingla, with doses increased as the opioid dose increases 5.
  • Adequate fluid intake and dietary fiber should be maintained, though bulk-forming agents like Metamucil are unlikely to control opioid-induced constipation 5.

Critical Warnings

  • Hysingla carries risks of addiction, abuse, misuse, respiratory depression, and overdose that are inherent to all μ-opioid analgesics 1.
  • It is indicated only for severe chronic pain requiring daily, around-the-clock, long-term opioid treatment when alternative options are inadequate 1.

Clinical Pearls

The abuse-deterrent formulation of Hysingla makes it harder to manipulate physically (crushing, chewing), which is designed to deter intranasal, intravenous, and certain forms of oral abuse 1. However, the medication will still be subject to misuse despite these properties 6.

References

Guideline

Administration of Cephalexin with Food

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gabapentin Administration and Food Interactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Extended-release hydrocodone (Hysingla ER) for pain.

The Medical letter on drugs and therapeutics, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.